HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus.

AbstractBACKGROUND:
Topical tacrolimus has been reported to be an effective treatment for genital lichen planus in small case series. We retrospectively reviewed the medical records of 16 patients with symptomatic vulvar lichen planus who received treatment with tacrolimus ointment.
OBSERVATIONS:
All patients had symptomatic vulvar lichen planus recalcitrant to other treatments. Of 16 patients, 15 (94%) experienced a symptomatic response to tacrolimus treatment within 3 months (mean, 4.2 weeks) and had a partial or complete resolution of the lesions. Six patients (38%) reported mild adverse effects, including irritation, burning, and tingling. With continued use of the medication, these adverse effects resolved. When patients stopped treatment, lichen planus returned in 10 (83%) of 12 patients within 6 months after discontinuation of therapy (median, 1 week; range, 0.3-24 weeks), but in 6 patients the lesions were less severe than the lesions before treatment; all 10 patients resumed use of topical tacrolimus.
CONCLUSIONS:
In this retrospective series of 16 women with vulvar lichen planus, topical tacrolimus therapy effectively controlled symptoms and improved lesions in all but 1 patient. The effect may be temporary, requiring continued use of tacrolimus, which appears to be safe and effective in controlling disease activity.
AuthorsJulie A Byrd, Mark D P Davis, Roy S Rogers 3rd
JournalArchives of dermatology (Arch Dermatol) Vol. 140 Issue 6 Pg. 715-20 (Jun 2004) ISSN: 0003-987X [Print] United States
PMID15210463 (Publication Type: Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Tacrolimus
Topics
  • Administration, Cutaneous
  • Aged
  • Drug Administration Schedule
  • Female
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Lichen Planus (drug therapy, epidemiology, pathology)
  • Medical Records
  • Middle Aged
  • Minnesota (epidemiology)
  • Recurrence
  • Retrospective Studies
  • Tacrolimus (administration & dosage)
  • Treatment Outcome
  • Vulvar Diseases (drug therapy, epidemiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: